Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
germany (6) 6
oncology (6) 6
recombinant proteins (6) 6
cancer (5) 5
darbepoetin alfa (5) 5
erythropoietin - analogs & derivatives (5) 5
index medicus (5) 5
neoplasms - complications (5) 5
quality-of-life (5) 5
randomized controlled trials as topic (5) 5
evidence-based medicine (4) 4
female (4) 4
phase-iii trial (4) 4
placebo-controlled trial (4) 4
platinum-based chemotherapy (4) 4
adult (3) 3
anemia (3) 3
anemia - drug therapy (3) 3
anemia - etiology (3) 3
cell lung-cancer (3) 3
clinical trials (3) 3
colony-stimulating factor (3) 3
darbepoetin-alpha (3) 3
double-blind (3) 3
erythrocyte transfusion (3) 3
erythropoietin - adverse effects (3) 3
erythropoietin - therapeutic use (3) 3
hematinics - therapeutic use (3) 3
lymphoma, non-hodgkin - drug therapy (3) 3
male (3) 3
medicine, general & internal (3) 3
neoplasms - drug therapy (3) 3
neoplasms - mortality (3) 3
patients receiving chemotherapy (3) 3
research design (3) 3
treatment outcome (3) 3
anemia, hypochromic - chemically induced (2) 2
anemia, hypochromic - drug therapy (2) 2
anemia, hypochromic - prevention & control (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
care and treatment (2) 2
chemotherapy (2) 2
comparative analysis (2) 2
complications and side effects (2) 2
epoetin alfa (2) 2
epoetin-alpha (2) 2
erythropoietin, recombinant (2) 2
family physicians (2) 2
health aspects (2) 2
health care surveys (2) 2
hematinics - adverse effects (2) 2
hematologic neoplasms - drug therapy (2) 2
implementation (2) 2
information services (2) 2
meta-analysis (2) 2
multicenter studies as topic (2) 2
non-hodgkins-lymphoma (2) 2
patient participation (2) 2
practice guidelines as topic (2) 2
quality assurance, health care (2) 2
quality of life (2) 2
recombinant-human-erythropoietin (2) 2
risk factors (2) 2
societies, medical (2) 2
survival analysis (2) 2
thromboembolism - chemically induced (2) 2
weekly epoetin-alpha (2) 2
1st complete remission (1) 1
abridged index medicus (1) 1
acute myeloblastic-leukemia (1) 1
acute myelogenous leukemia (1) 1
acute myeloid-leukemia (1) 1
adolescent (1) 1
aged (1) 1
agency for quality in medicine (1) 1
allogeneic transplant (1) 1
anemia - complications (1) 1
anemia - mortality (1) 1
anemia - physiopathology (1) 1
anemia - prevention & control (1) 1
anemia - therapy (1) 1
anemia [drug therapy; etiology] (1) 1
anemia, hypochromic - etiology (1) 1
anemia, hypochromic - therapy (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, murine-derived (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
b-cell lymphoma (1) 1
bedarfserhebung (1) 1
blood transfusion (1) 1
blood-transfusion (1) 1
bone-marrow-transplantation (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - therapy (1) 1
breast-cancer (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
by Bohlius, Julia, MD and Schmidlin, Kurt, DMD and Brillant, Corinne, MSc and Schwarzer, Guido, PhD and Trelle, Sven, MD and Seidenfeld, Jerome, PhD and Zwahlen, Marcel, PhD and Clarke, Michael, Prof and Weingart, Olaf, MD and Kluge, Sabine, MA and Piper, Margaret, PhD and Rades, Dirk, MD and Steensma, David P, MD and Djulbegovic, Benjamin, Prof and Fey, Martin F, Prof and Ray-Coquard, Isabelle, MD and Machtay, Mitchell, Prof and Moebus, Volker, Prof and Thomas, Gillian, Prof and Untch, Michael, Prof and Schumacher, Martin, Prof and Egger, Matthias, Prof and Engert, Andreas, Prof
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1532 - 1542
Summary Background Erythropoiesis-stimulating agents reduce anaemia in patients with cancer and could improve their quality of life, but these drugs might... 
Internal Medicine | CELL LUNG-CANCER | PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | NON-HODGKINS-LYMPHOMA | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | CHRONIC KIDNEY-DISEASE | WEEKLY EPOETIN-ALPHA | PATIENTS RECEIVING CHEMOTHERAPY | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Young Adult | Neoplasms - complications | Anemia - drug therapy | Adult | Female | Anemia - etiology | Effect Modifier, Epidemiologic | Hematinics - therapeutic use | Erythrocyte Transfusion | Proportional Hazards Models | Neoplasms - mortality | Hematinics - adverse effects | Linear Models | Survival Rate | Treatment Outcome | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Adolescent | Aged | Research Design | Prevention | Complications and side effects | Care and treatment | Anemia | Research | Comparative analysis | Blood transfusion | Health aspects | Risk factors | Erythropoietin, Recombinant | Cancer | Studies | Clinical trials | Radiation therapy | Mortality | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Erythropoietin or darbepoetin for patients with cancer
by Tonia, Thomy and Mettler, Annette and Robert, Nadège and Schwarzer, Guido and Seidenfeld, Jerome and Weingart, Olaf and Hyde, Chris and Engert, Andreas and Bohlius, Julia
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 12, Issue 12, p. CD003407
Background Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives... 
CHEMOTHERAPY-INDUCED-ANEMIA | COLONY-STIMULATING FACTOR | Anemia [drug therapy; etiology] | Humans | RECOMBINANT-HUMAN-ERYTHROPOIETIN | Recombinant Proteins | WEEKLY EPOETIN-BETA | Erythropoietin [analogs & derivatives; therapeutic use] | Randomized Controlled Trials as Topic | PHASE-III TRIAL | CELL LUNG-CANCER | EVERY 3 WEEKS | MEDICINE, GENERAL & INTERNAL | Neoplasms [blood; complications] | PATIENTS RECEIVING RADIOTHERAPY | Erythrocyte Transfusion [utilization] | PLATINUM-BASED CHEMOTHERAPY | QUALITY-OF-LIFE | Recombinant Proteins - therapeutic use | Thromboembolism - chemically induced | Erythropoietin - therapeutic use | Erythropoietin - adverse effects | Anemia - prevention & control | Recombinant Proteins - adverse effects | Cause of Death | Erythropoietin - analogs & derivatives | Neoplasms - complications | Anemia - drug therapy | Neoplasms - blood | Hypertension - chemically induced | Erythrocyte Transfusion - utilization | Quality of Life | Darbepoetin alfa | Anemia - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
by Bohlius, Julia and Wilson, Jayne and Seidenfeld, Jerome and Piper, Margaret and Schwarzer, Guido and Sandercock, Josie and Trelle, Sven and Weingart, Olaf and Bayliss, Sue and Djulbegovic, Benjamin and Bennett, Charles L and Langensiepen, Simon and Hyde, Chris and Engert, Andreas
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2006, Volume 98, Issue 10, pp. 708 - 714
This is an updated systematic review of 57 trials and 9353 cancer patients from articles, abstracts, and reports published between January 1, 1985, and April... 
PHASE-III TRIAL | MULTIPLE-MYELOMA | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | DOUBLE-BLIND | NON-HODGKINS-LYMPHOMA | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | EPOETIN-ALPHA | PATIENTS RECEIVING CHEMOTHERAPY | DARBEPOETIN-ALPHA | Anemia, Hypochromic - drug therapy | Anemia, Hypochromic - prevention & control | Hematinics - therapeutic use | Risk Assessment | Thromboembolism - chemically induced | Erythrocyte Transfusion | Erythropoietin - therapeutic use | Humans | Treatment Outcome | Antineoplastic Agents - administration & dosage | Recombinant Proteins | Thromboembolism - epidemiology | Anemia, Hypochromic - therapy | Incidence | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Erythropoietin - analogs & derivatives | Antineoplastic Agents - adverse effects | Anemia, Hypochromic - chemically induced | Epoetin Alfa | Darbepoetin alfa | Research Design | Case studies | Cancer patients | Usage | Drug therapy | Health aspects | Erythropoietin, Recombinant | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data
by Bohlius, Julia and Schmidlin, Kurt and Brillant, Corinne and Schwarzer, Guido and Trelle, Sven and Seidenfeld, Jerome and Zwahlen, Marcel and Clarke, Mike J and Weingart, Olaf and Kluge, Sabine and Piper, Margaret and Napoli, Maryann and Rades, Dirk and Steensma, David and Djulbegovic, Benjamin and Fey, Martin F and Ray-Coquard, Isabelle and Moebus, Volker and Thomas, Gillian and Untch, Michael and Schumacher, Martin and Egger, Matthias and Engert, Andreas
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2009, Issue 3, p. CD007303
Background Erythropoiesis-stimulating agents (ESAs) reduce anemia in cancer patients and may improve quality of life, but there are concerns that ESAs might... 
CELL LUNG-CANCER | PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | WEEKS ALLEVIATES ANEMIA | CHEMOTHERAPY-INDUCED ANEMIA | COLONY-STIMULATING FACTOR | RECOMBINANT-HUMAN-ERYTHROPOIETIN | PLATINUM-BASED CHEMOTHERAPY | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | WEEKLY EPOETIN-ALPHA | Anemia - mortality | Erythrocyte Transfusion | Humans | Erythropoietin - adverse effects | Neoplasms - mortality | Anemia - therapy | Hematinics - adverse effects | Male | Recombinant Proteins | Randomized Controlled Trials as Topic | Disease-Free Survival | Erythropoietin - analogs & derivatives | Neoplasms - complications | Anemia - complications | Neoplasms - therapy | Adult | Female | Epoetin Alfa | Darbepoetin alfa | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text EbM von unten: Sind Fragen nach Evidenz zu klinischen Alltagsproblemen beantwortbar?
by Blank, Wolfgang and Weingart, Olaf
Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, ISSN 1865-9217, 2009, Volume 103, Issue 7, pp. 425 - 430
Many physicians agree on the advantages of using Evidence-based Medicine (EbM) in daily practice, but they do not make use of this method very often. One... 
Health care surveys | Information services | Evidence-based medicine | Implementation | Family physicians
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text EbM von unten: Sind Fragen nach Evidenz zu klinischen Alltagsproblemen beantwortbar?
by Blank, Wolfgang and Weingart, Olaf
Zeitschrift fuer Evidenz, Fortbildung und Qualitaet im Gesundheitswesen, ISSN 1865-9217, 2009, Volume 103, Issue 7, pp. 425 - 430
Viele Ärzte sehen Vorteile in der Anwendung evidenzbasierter Medizin (EbM) im Alltag. Dennoch wird deren Umsetzung in die Patientenversorgung nur in geringem... 
Implementierung | family physicians | Evidence-based Medicine | health care surveys | implementation | Evidenzbasierte Medizin | Informationsmanagement | Hausärzte | information services | Bedarfserhebung
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights